Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japan

Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japan - ISLAND-J study

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031210002

Enrollment

Registered

2021-04-01

Start date

2022-01-07

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

protocol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: protocol

Exclusion criteria

Exclusion criteria: protocol

Design outcomes

Primary

Measure	Time frame
3 year over-all survival	—

Secondary

Measure	Time frame
protocol	—

Contacts

Public ContactAkinori Watanabe

Kitasato university Hospital

akinori@kitasato-u.ac.jp+81-42-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026